TY  - JOUR
T1  - COnflict of interest, disclosure, and trial reports
AU  - Psaty BM
Y1  - 2009/04/08
N1  - 10.1001/jama.2009.466
JO  - JAMA
SP  - 1477
EP  - 1479
VL  - 301
IS  - 14
N2  - 
When I was an assistant professor, my previous training had not prepared me for the unexpected attention that 2 articles, both from the same study, were to receive. One article provided evidence that abruptly stopping β-blockers might increase the risk of coronary events.1 The other suggested that, compared with the use of high-dose diuretics, which is now no longer recommended, the use of β-blockers might be associated with a lower risk of coronary events in hypertensive patients.2 While the news media's coverage of the risk study was transient, the pharmaceutical industry had a more sustained interest in the other publication.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.466
UR  - http://dx.doi.org/10.1001/jama.2009.466
ER  -